Addiction Psychiatry Annual REVIEW: 2023 Highest Impact Publications-Addiction Psychiatry Annual REVIEW: 2023 Highest Impact Publications

Video Transcription

Video Summary

The annual meeting featured a session that focused on cannabis, opioids, and telehealth services. In the study on cannabis use and psychiatric disease, it was found that cannabis use was associated with an increased risk of depression, bipolar disorder, and psychotic bipolar disorder. However, the association with depression was not as strong as the association with bipolar disorder. Another study examined the impact of state cannabis laws on psychosis-related healthcare utilization and found no significant increase in diagnoses or prescribed antipsychotics in states with cannabis legalization.<br /><br />Moving on to opioids, a study found higher rates of all-cause mortality and fatal drug overdoses in the pandemic cohort compared to the pre-pandemic cohort. However, the percentage of deaths due to fatal overdose was similar in both groups. Additionally, the study found that receiving extended-release naltrexone in office-based settings was not associated with a lower risk of fatal drug overdose, while receiving opioid use disorder-related telehealth was associated with a lower odds of fatal drug overdose in the pandemic cohort.<br /><br />During the discussion, the panel covered studies on racial disparities in the receipt of medications for opioid use disorder, the impact of adverse childhood experiences on treatment outcomes, and the use of digital therapeutics for substance use disorders. They also discussed the effectiveness of telehealth services and office-based treatment for opioid use disorder during the pandemic. The panel emphasized the need for patient-centered care and addressing structural barriers to access in addiction treatment.<br /><br />Overall, the session provided insights into the impact of cannabis, opioids, and telehealth on mental health and healthcare utilization, as well as the challenges and opportunities in addiction medicine.

Keywords

cannabis

opioids

telehealth services

psychiatric disease

depression

bipolar disorder

psychosis-related healthcare utilization

opioid use disorder

fatal drug overdoses

telehealth

pandemic cohort

digital therapeutics

addiction treatment

	The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.		400 Massasoit Avenue Suite 108 East Providence, RI 02914 cmecpd@aaap.org Privacy	About Advocacy Membership Fellowship Education and Resources Training Events